| Stage | CHRD | % of rev | EOG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.7B | 100.00% | $8.3B | 100.00% | EOG ×4.87 |
| Gross profit | $1.3B | 77.85% | $7.1B | 85.72% | EOG +7.9pp |
| Operating income | $505M | 29.60% | $3.6B | 43.17% | EOG +13.6pp |
| Pre-tax income | $246M | 14.40% | $3.6B | 42.90% | EOG +28.5pp |
| Net income | $182M | 10.64% | $2.8B | 33.48% | EOG +22.8pp |
| Stage | CHRD | EOG | Gap · A − B |
|---|---|---|---|
| Revenue | $1.7B100.00% | $8.3B100.00% | EOG ×4.87 |
| Gross profit | 77.85%$1.3B | 85.72%$7.1B | EOG +7.9pp |
| Operating income | 29.60%$505M | 43.17%$3.6B | EOG +13.6pp |
| Pre-tax income | 14.40%$246M | 42.90%$3.6B | EOG +28.5pp |
| Net income |
| 10.64%$182M |
| 33.48%$2.8B |
| EOG +22.8pp |
No shared counterparties.